| Project/Area Number |
22791348
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Cerebral neurosurgery
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
MIZOBUCHI Yoshifumi 徳島大学, 大学院・ヘルスバイオサイエンス研究部, 助教 (80547993)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 脳腫瘍 / REIC-Dkk3 / Wntシグナル / REIC-DKK-3 / 遺伝子治療 |
|---|
| Research Abstract |
Reduced expression in immortalized cells/ Dikkofp-3(REIC/ DKK3, REIC), a tumor suppressor gene, has been investigated in gene therapy studies in various cancers. Elsewhere we first demonstrated that REIC was down-regulated in glioblastoma(GBM) cells, and that its over-expression with plasmid vector drastically inhibited their growth via activation of intrinsic apoptotic pathway. However, whether adenovirus-mediated overexpression of REIC(Ad-REIC) contributes to anti-tumor effect in glioma remain unclear. We performed this study to assess the applicability of Ad-REIC in GBM and to verify the molecular mechanisms underlying anti-tumor effect of Ad-REIC We first document that Ad-REIC effectively inhibited the growth of GBM in a time-and dose dependent manner and induced apoptosis. We also found that Ad-REIC reduced expression of Wnt proteins and its receptor LRP6 but not ROR2 Our data suggest that interfering the activation of both canonical-and non-canonical Wnt signaling pathway via overexpression of REIC contributes at least partly to suppress cell survival in GBM.
|
